{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:15:23Z","timestamp":1785176123601,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5977,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.nurt.2007.01.007","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:19:14Z","timestamp":1175066354000},"page":"305-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Autoimmune and Paraneoplastic Channelopathies"],"prefix":"10.1016","volume":"4","author":[{"given":"Steven","family":"Vernino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.01.007_bib1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrc1255","article-title":"Paraneoplastic neurological degenerations: keys to tumour immunity","volume":"4","author":"Albert","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nurt.2007.01.007_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0025-6196(12)61144-6","article-title":"Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma","volume":"67","author":"Oguro-Okano","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nurt.2007.01.007_bib4","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1046\/j.1471-4159.1997.69062302.x","article-title":"Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma","volume":"69","author":"Sciamanna","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2007.01.007_bib5","series-title":"Immunologic mechanisms in neurologic and psychiatric disease","first-page":"183","article-title":"How to recognize an antibody-mediated autoimmune disease: criteria","author":"Drachman","year":"1990"},{"key":"10.1016\/j.nurt.2007.01.007_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nurt.2007.01.007_bib7","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nurt.2007.01.007_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1976.tb47694.x","article-title":"End-plate potentials in experimental autoimmune myasthenia gravis in rats","volume":"274","author":"Lambert","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nurt.2007.01.007_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptors","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.01.007_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib11","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1073\/pnas.96.10.5746","article-title":"Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor","volume":"96","author":"Xu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2007.01.007_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/gast.2001.26320","article-title":"Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit","volume":"121","author":"Richardson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nurt.2007.01.007_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1212\/WNL.44.9.1675","article-title":"Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients","volume":"44","author":"Suarez","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"53","author":"Klein","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10286-002-0020-3","article-title":"Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor","volume":"12","author":"Goldstein","year":"2002","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nurt.2007.01.007_bib18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa051719","article-title":"Plasma exchange for primary autoimmune autonomic failure","volume":"353","author":"Schroeder","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib19","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1566-0702(01)00239-9","article-title":"Myasthenia gravis with autoimmune autonomic neuropathy","volume":"88","author":"Vernino","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.nurt.2007.01.007_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.74.9.1294","article-title":"Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension","volume":"74","author":"Singer","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.01.007_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","article-title":"Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease","volume":"111","author":"Lennon","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.01.007_bib23","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.1485-04.2004","article-title":"Passive transfer of autoimmune autonomic neuropathy to mice","volume":"24","author":"Vernino","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.01.007_bib24","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1152\/jn.00408.2003","article-title":"Experimental autoimmune autonomic neuropathy","volume":"90","author":"Vernino","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.nurt.2007.01.007_bib25","doi-asserted-by":"crossref","unstructured":"Pietroban D. Familial hemiplegic migraine. NeuroRx2007;4.","DOI":"10.1016\/j.nurt.2007.01.008"},{"key":"10.1016\/j.nurt.2007.01.007_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nurt.2007.01.003","article-title":"Molecular pathogenesis of spinocerebellar ataxia type 6 (SCA6)","volume":"4","author":"Kordasiewicz","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nurt.2007.01.007_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mus.880111105","article-title":"Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities","volume":"11","author":"Lambert","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.01.007_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410420204","article-title":"Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse","volume":"42","author":"Waterman","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8619(18)30103-8","article-title":"Diagnosis and treatment of Lambert-Eaton myasthenic syndrome","volume":"12","author":"McEvoy","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.nurt.2007.01.007_bib30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/brain\/124.11.2223","article-title":"The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders","volume":"124","author":"Rees","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib32","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.42.10.1944","article-title":"Paraneoplastic cerebellar degeneration","volume":"42","author":"Clouston","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.10392","article-title":"Reduction of P\/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome","volume":"53","author":"Fukuda","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nurt.2007.01.010","volume":"4","author":"Rajakulendran","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nurt.2007.01.007_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/brain\/122.5.817","article-title":"A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy","volume":"122","author":"Zuberi","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib37","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.01.007_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs\u2019 syndrome) report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib40","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/mus.880171103","article-title":"AAEM Minimonograph #44: diseases associated with excess motor unit activity","volume":"17","author":"Auger","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nurt.2007.01.007_bib41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/WNL.41.7.1021","article-title":"Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder","volume":"41","author":"Tahmoush","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1996.00550020113023","article-title":"Rippling muscles and myasthenia gravis with rippling muscles","volume":"53","author":"Ansevin","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib43","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/brain\/awl084","article-title":"Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations","volume":"129","author":"Kleopa","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(91)90073-X","article-title":"Autoimmune aetiology for acquired neuromyotonia (Isaacs\u2019 syndrome)","volume":"338","author":"Sinha","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2007.01.007_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00868410","article-title":"Morvan\u2019s fibrillary chorea: remission after plasmapheresis","volume":"243","author":"Madrid","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib47","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp.59.4.448","article-title":"Improvement of Isaacs\u2019 syndrome after treatment with azathioprine","volume":"59","author":"Riche","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.01.007_bib48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.20221","article-title":"Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia","volume":"56","author":"Tomimitsu","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed potassium channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib50","first-page":"1235","article-title":"Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders","volume":"39","author":"Arimura","year":"1999","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nurt.2007.01.007_bib51","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","article-title":"Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis","volume":"78","author":"Lawn","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nurt.2007.01.007_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.nurt.2007.01.007_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.54.3.771","article-title":"Morvan\u2019s syndrome associated with voltage-gated K+ channel antibodies","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib56","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0140-6736(03)12983-2","article-title":"Amnesia, cerebral atrophy, and autoimmunity","volume":"361","author":"Schott","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2007.01.007_bib57","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.10713","article-title":"Voltage-gated potassium channel antibodies in limbic encephalitis","volume":"54","author":"Pozo-Rosich","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.01.007_bib60","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen\u2019s encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.01.007_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00261-8","article-title":"Antibodies against GluR3 peptides are not specific for Rasmussen\u2019s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures","volume":"131","author":"Mantegazza","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.01.007_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/NMM:7:3:243","article-title":"T-cells in human encephalitis","volume":"7","author":"Bien","year":"2005","journal-title":"NeuroMolecular Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib64","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000191566.86977.04","article-title":"Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis","volume":"65","author":"Watson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.01.007_bib65","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2007.01.007_bib66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nurt.2007.01.007_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.01.007_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300661X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300661X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.01.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:38:15Z","timestamp":1761806295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792300661X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S187874792300661X"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.01.007","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune and Paraneoplastic Channelopathies","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}